Navigation Links
Carnegie Mellon develops non-invasive technique to detect transplant rejection at cellular level

Carnegie Mellon University scientist Chien Ho and his colleagues have developed a promising tool that uses magnetic resonance imaging (MRI) to track immune cells as they infiltrate a transplanted heart in the early stages of organ rejection. This pre-clinical advance, described in an upcoming issue of the Proceedings of the National Academy of Sciences (PNAS), ultimately could provide a non-invasive way to detect transplant rejection in patients.

"We have reported for the first time the ability to monitor single immune cells in a live animal using MRI. This could revolutionize the management of transplant patients," said Ho, professor of biological sciences at the Mellon College of Science.

"Successful translation of this work to the clinic ultimately will reduce the number of biopsy procedures and should greatly improve the quality of life for cardiac transplant patients, especially children," added Ho, who directs the Pittsburgh NMR Center for Biomedical Research. "Perhaps most importantly, this advance will allow doctors to provide highly personalized care that could prevent transplant rejection."

Organ transplantation is the preferred clinical approach to treat end-stage organ failure, but transplant patients face a lifetime of immunosuppressive therapy and the risk of losing the new organ due to rejection. Physicians typically monitor patients for organ rejection following a heart transplant by performing frequent heart biopsies for the first year. Heart biopsies are invasive procedures that involve threading a catheter through the jugular vein to the heart's right ventricle and snipping out several tiny pieces of tissue. A pathologist then tests the tissue to identify the presence of immune cells (such as macrophages) as well as other pathological changes in the transplanted heart tissue that indicate the graft is being rejected by the body's immune system.

These procedures are costly, uncomfortable and must be repeated annually for a few years to monitor and treat any rejection. Biopsies also are problematic, according to Ho, because they do not look at the whole organ. By only sampling several small areas, a biopsy may miss the area of the transplanted organ where immune cells are gathering -- one of the first signs of rejection.

Ho's novel approach investigates transplant rejection non-invasively by observing macrophage accumulation in heart tissues using MRI.

"We were able to use MRI to visualize individual macrophages. By tracking individual cells, we also were able to observe, for the first time, that rejection progresses from the outside of the heart to the inside," said Ho. "Up to now, this phenomenon hasn't been observed in pre-clinical or clinical research because biopsy samples are very limited in location and size."

The reported findings also have broader implications for biology and medicine, according to Ho.

"We now have the ability to visualize non-invasively and with sensitivity individual cells and their movement to targeted sites. Our new approach offers almost unlimited potential for monitoring cell therapies, such as those using stem cells, and for tracking cellular and developmental processes," Ho said.

For the research reported in PNAS, Yijen Wu, research biologist at the Pittsburgh NMR Center for Biomedical Research, tagged macrophages with nanometer (USPIO)- or micrometer (MPIO)-sized paramagnetic iron oxide particles, which are very sensitive to the magnetic fields used during MRI. Wu injected the MPIO or USPIO particles into rats that had received heart transplants three days earlier. Macrophages, which typically ingest foreign materials inside the body (bacteria, for example), incorporated the particles. Using MRI, the researchers then track tagged macrophages that infiltrate transplanted hearts. The locations of the tagged macrophages are highly defined and appear circular in shape, said Wu. This finding indicates that the new, real-time tracking method is very good at pinpointing exactly when and where rejection is taking place.

The researchers used a heterotropic heart model to study organ rejection. In this model, a rat receives a second functional heart, which is grafted into its abdomen. The rat's native heart functions normally. In this way, the researchers can study how a transplanted heart changes through sequential stages of rejection while the rat stays healthy. This aspect of the research was conducted primarily by Qing Ye, a research biologist at the Pittsburgh NMR Center for Biomedical Research.

Ho's team at the Pittsburgh NMR Center for Biomedical Research is now pursuing research using larger animal models. They are collaborating with researchers at the University of Pittsburgh School of Medicine, including Dr. David Cooper, professor of surgery in the Thomas E. Starzl Transplantation Institute; Dr. Jeffrey Teuteberg, assistant professor of medicine at the Cardiovascular Institute, Heart Failure/Transplantation; and Dr. Fernando Boada, associate professor in the Department of Radiology.


'"/>

Source:Carnegie Mellon University


Related biology news :

1. Carnegie Mellon scientists develop tool that uses MRI to visualize gene expression in living animals
2. Robot-based system developed at Carnegie Mellon detects life in Chiles Atacama desert
3. Green catalyst destroys pesticides and munitions toxins, finds Carnegie Mellon University
4. Carnegie Mellon University research reveals how cells process large genes
5. Carnegie Mellon cyLab researchers work to develop new red tide monitoring
6. Team led by Carnegie Mellon University scientist finds first evidence of a living memory trace
7. Carnegie Mellon scientists create PNA molecule with potential to build nanodevices
8. Carnegie Mellon U. transforms DNA microarrays with standard Internet communications tool
9. Carnegie Mellon scientists show brain uses optimal code for sound
10. DNA conclusive yet still controversial, Carnegie Mellon professor says
11. Teens unaware of sexually transmitted diseases until they catch one, Carnegie Mellon study finds
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/7/2017)... , March 7, 2017   HireVue , the ... global companies identify the best talent, faster, today announced ... Sales Officer (CSO) and Diana Kucer as ... out a seasoned executive team poised to drive continued growth ... on a year of record bookings in 2017. ...
(Date:3/2/2017)... 2017 Who risk to be deprived of ... full report: https://www.reportbuyer.com/product/4313699/ WILL APPLE AND ... Fingerprint sensors using capacitive technology represent a fast ... Idex forecasts an increase of 360% of the number ... the fingerprint sensor market between 2014 and 2017 (source ...
(Date:2/28/2017)... News solutions for biometrics, bag drop and New ADA-compliant ... At PTE ... March, Materna will present its complete end-to-end passenger journey, ... real benefit for passengers. To accelerate the whole passenger handling ... solutions to take passengers through the complete integrated process with ...
Breaking Biology News(10 mins):
(Date:3/24/2017)... Research and Markets has announced the addition of the "Human ... report to their offering. ... This report analyzes the Global market for Human Embryonic ... are provided for the period 2014 through 2022. Market data and ... The report profiles 25 companies including many key and niche players ...
(Date:3/24/2017)... 24, 2017   Sienna Biopharmaceuticals, Inc. , a ... announced that Richard Peterson will join the ... Peterson, who brings more than two decades of ... who is retiring at the end of April but ... Peterson joins Sienna from Novan, Inc., where he served ...
(Date:3/23/2017)... , ... March 23, 2017 , ... Lajollacooks4u is proud to announce it has become ... hosted corporate cooking challenges for companies around the world, such as Illumina, HP and Qualcomm, ... the reason for its increasing popularity is due to its new team building format, a ...
(Date:3/23/2017)... Mass. , March 23, 2017 /PRNewswire/ ... partner to global in vitro diagnostics manufacturers ... of the industry,s first multiplexed Inherited ... disease testing by next-generation sequencing (NGS). The ... were developed with input from industry experts ...
Breaking Biology Technology: